Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

ajanta pharma

Tag: ajanta pharma

Read all Latest Updates and news on and about Ajanta Pharma - Page 2

Ajanta Pharma is a multinational company based in India engaged in development, manufacturing, and marketing of pharma formulations. - Latest News and Information

Ajanta Pharma to add liquid formulation facility at Pithampur site

Ajanta Pharma looks to expand ops in high-growth Asian, African geographies

Ruchika Sharma3 July 2023 1:30 PM IST

"We plan to ramp up our presence in these markets and add value to the patients' choices through our differentiated product portfolio," the drug firm...

Ajanta Pharma Dahej facility concludes USFDA inspection with no Form 483

Ruchika Sharma26 Jun 2023 11:08 AM IST

Mumbai: Ajanta Pharma has recently announced that the US Food and Drug Administration (USFDA) has concluded an inspection at the Company's Dahej...

Ajanta Pharma gets CDSCO Panel Nod to manufacture, market high blood pressure FDC drug

Dr. Divya Colin28 May 2023 5:45 PM IST

New Delhi: Ajanta Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...

Ajanta Pharma records India's largest CPR campaign, Gets Recognised by Asia Book of Records

MD Brand Connect30 March 2023 4:02 PM IST

Mumbai: Ajanta Pharma, a specialty pharmaceutical formulation company, made it to the Asia Book of Records by conducting the largest life-saving CPR...

Ajanta Pharma gets CDSCO Panel nod to study Tadalafil Oral Jelly for erectile dysfunction

Dr. Divya Colin3 Jan 2023 5:30 PM IST

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...

Ajanta Pharma Promoter entities sell 4.3 percent stake for Rs 637 crore

Ruchika Sharma24 Dec 2022 10:00 AM IST

New Delhi: Promoter entities of Ajanta Pharma has divested 4.3 percent stake in the company for Rs 637 crore through open market transactions. The...

Ajanta Pharma conferred as "Best Managed Companies" in India by Deloitte

Ruchika Sharma18 Oct 2022 2:30 PM IST

Mumbai: Ajanta Pharma, a specialty pharmaceutical formulation company, has been awarded as "Best Managed Companies" in India by Deloitte for 2022. ...

Ajanta Pharma Dahej facility gets 2 procedural observations from USFDA

Ruchika Sharma13 Sept 2022 12:15 PM IST

The formulation facility was inspected by USFDA from 5th September 2022 to 9th September 2022.

Ajanta Pharma board nod to Rs 286-crore share buyback plan

Ruchika Sharma29 Dec 2021 11:00 AM IST

New Delhi: Drug firm Ajanta Pharma on Tuesday said its board has approved a share buyback plan of up to Rs 286-crore, wherein the drug maker...

NPPA panel fixes MRP of Ajanta Pharma Metoprolol Tartrate, lvabradine Hydrochloride FDC

Medical Dialogues Team15 Oct 2021 11:55 AM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the price of the Fixed Dose Combination (FDC) of each film coated...

Ajanta Pharma lines up capex plan of Rs 250 crore for FY22

Ruchika Sharma10 May 2021 2:01 PM IST

New Delhi: Drug maker Ajanta Pharma has lined up a capex plan of Rs 250 crore for the current fiscal as it looks to expand its corporate office and...

Zydus Lifesciences venture capital arm invests in Feldan Therapeutics

ABCD Technologies onboards 9 new investors including Glenmark, Alembic pharma

Medical Dialogues Team5 May 2021 12:47 PM IST

New Delhi: With the aim of building the IT infrastructure and supply chain required for pharmaceutical distribution, ABCD Technologies LLP (to be...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok